Comparison of 68Ga-PSMA PET/CT and Contrast-Enhanced MRI on Residual Disease Assessment of Juvenile Nasal Angiofibroma

Clin Nucl Med. 2020 Apr;45(4):308-309. doi: 10.1097/RLU.0000000000002951.

Abstract

Prostate-specific membrane antigen (PSMA) is expressed in the endothelial cells of tumor-associated neovasculature of various nonprostatic benign and malignant neoplasms including juvenile nasopharyngeal angiofibroma (JNA). Positive uptake on PET/CT imaging with Ga-labeled PSMA is noted in a patient with residual disease after initial surgery without any abnormal uptake in postoperative fibrosis, in contrast to contrast-enhanced MRI, which was confirmed by biopsy. Ga-PSMA PET/CT may be a useful tool clinically for identifying early biochemical recurrences and in specifically differentiating recurrences from surgical site reparative tissue.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Angiofibroma / diagnostic imaging*
  • Gallium Isotopes
  • Gallium Radioisotopes
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Membrane Glycoproteins
  • Organometallic Compounds
  • Positron Emission Tomography Computed Tomography*
  • Radiopharmaceuticals

Substances

  • Gallium Isotopes
  • Gallium Radioisotopes
  • Membrane Glycoproteins
  • Organometallic Compounds
  • Radiopharmaceuticals
  • gallium 68 PSMA-11